China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals, Inc. is an innovative pharmaceutical company based in China that focuses on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP). TCMP are a type of Chinese Traditional Medicine (TCM) products. The company operates as an offshore holding company, conducting all business through its subsidiaries and variable interest entity, Taizhou Suxuantang, in China. Neither China SXT Pharmaceuticals, Inc. nor its subsidiaries own shares in Taizhou Suxuantang. Instead, a wholly foreign-owned enterprise (WFOE), Taizhou Suxuantang, and its shareholders have entered into a series of contractual arrangements, known as VIE Agreements. These agreements allow China SXT Pharmaceuticals, Inc. to be regarded as the primary beneficiary of Taizhou Suxuantang for accounting purposes, enabling the consolidation of Taizhou Suxuantang's financial results in the company's consolidated financial statements in accordance with U.S. GAAP. The company's operations in China are governed by PRC laws and regulations, and its PRC subsidiaries and variable interest entities are subject to laws and regulations applicable to foreign investments in China and wholly foreign-owned enterprises.